Understanding Neuroretinitis
The classic pattern includes a swollen optic disc and deposits arranged around the macula, often called a macular star. The disc is the nerve head seen at the back of the eye; the macula supports detailed central vision. These are clinician-observed findings, not a star that the patient necessarily sees. [1] [2]
Bartonella henselae, associated with cat-scratch disease, is an important cause, but not the only one. Other infections, inflammatory disorders and idiopathic cases occur. Exposure history, immune status and geography change the investigation; a small Korean series illustrates why a worldwide assumption that every case comes from cats is misleading. [3] [4]
One condition. Different experiences.
Explore different selected symptom features, then read how they may vary. These examples are not stages or a clinical test.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.
Central detail becomes difficult
Reading, recognizing faces or seeing a clear central target may become harder. Some people describe a central blind spot, reduced contrast or color, rather than uniform fog over the whole scene. [1] [2]
The experience may be painless
Vision often changes in one eye and may be painless; both eyes can be affected. Fever, malaise or enlarged lymph nodes may precede Bartonella-associated disease, but their absence does not establish another cause. [2] [5]
Appearance evolves over time
A macular star can be absent when vision first changes and become visible later. Symptoms, fluid, deposits and chart acuity do not necessarily recover at the same rate, which makes repeat examination useful. [1] [4]
Why the examination may change after symptoms begin
Original process schematic, not a fixed timetable, a view through the eye or proof of Bartonella. [1] [2] [3]
Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.- Disc leakage
Inflammation can cause leakage near the nerve head.
- Fluid spreads
Nearby retina and central detail can be affected.
- Deposits emerge
A macular star may become visible later.
- Cause matters
Investigation separates infectious and noninfectious explanations.
What is happening—and what remains uncertain
Inflammation and leakage at small vessels around the optic disc allow fluid and lipid-rich material to extend into nearby retina. As fluid changes, deposits become more conspicuous around the macula. OCT and angiography can show aspects of this process that an ordinary photograph may miss. [1] [2]
This appearance is not a single organism-specific signature. Some conditions produce a neuroretinitis-like pattern, while Bartonella can cause retinal inflammation, vascular occlusion or other ocular phenotypes without classic neuroretinitis. The clinician therefore identifies both the anatomical problem and its likely cause. [3] [6]
What can look similar?
Optic neuritis
Both conditions can disturb central vision and color. A leaking swollen disc with evolving macular deposits favors a different pattern from typical demyelinating optic neuritis, but atypical cases need additional investigation rather than a visual comparison alone. [1] [2]
Other causes of a swollen disc
Raised pressure, severe vascular disease and other optic-nerve disorders can cause disc swelling or associated retinal findings. A macular star does not replace blood-pressure measurement, neurological assessment or targeted imaging. [1] [3]
Infectious versus recurrent idiopathic disease
An infectious cause requires cause-directed decisions. Recurrent episodes without an identified cause form a different management problem; recurring loss should trigger reassessment rather than automatic repetition of an earlier antibiotic course. [3] [7]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- Document nerve and macular functionThe eye examination evaluates acuity, pupils, color, visual field, optic disc, retina and vitreous. OCT can document fluid and retinal changes; fluorescein angiography is selected when leakage, vascular occlusion or unusual lesions need clarification. [1] [3]
- Investigate exposure and systemic contextClinicians ask about animals, travel, recent illness, immune suppression and other symptoms, and select blood tests accordingly. A positive antibody result may reflect prior exposure or cross-reaction; a negative early result may need clinical reconsideration. [2] [5]
- Revisit an atypical or unresolved diagnosisMRI, further infection testing or specialist consultation may be needed if the presentation suggests another optic neuropathy or systemic disease. Follow-up is important because the initial absence of deposits does not exclude the evolving pattern. [1] [3]
What may help—and what is still being studied
Treat the identified cause
Management is tailored to the infection or inflammatory process and the severity of eye and systemic involvement. CDC advises specialist input for disseminated cat-scratch manifestations such as retinitis; this differs from uncomplicated lymph-node disease. [5]
Be clear about treatment uncertainty
Reviews find no high-quality randomized evidence establishing one universal antibiotic or steroid strategy for neuroretinitis. Spontaneous improvement in some immunocompetent Bartonella cases complicates interpretation of treatment series; this uncertainty is not a reason to skip assessment of sight-threatening disease. [3] [7]
Follow recovery and remaining disability
Repeat function testing and retinal imaging help detect recurrence, persisting fluid, structural damage or an alternative cause. Rehabilitation and temporary educational or workplace support can address practical limitations while medical follow-up continues. [1] [4] [9]
What this can mean for daily life
Reduce central-detail demands
Use larger type, text-to-speech and adjustable contrast while reading is difficult. A rehabilitation assessment can identify useful aids if central vision remains impaired. [9]
Describe each eye separately
Bring a short timeline of which eye changed and which tasks became difficult, alongside any systemic illness or exposure history. A drawing or simulation is a communication aid, not a substitute for examination. [1] [3]
Ask about infection prevention appropriately
CDC describes cat-scratch transmission involving scratches contaminated with flea material. Discuss prevention and pet-related questions with qualified professionals; having neuroretinitis does not by itself prove which animal or exposure was responsible. [5]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
Case series of neuroretinitis in Korea
Six of nine tested people had Toxocara antibodies and no suspected cat-scratch cases were identified, illustrating regional and exposure-related variation. [4]
Limits and applicability: Very small selected cohort. Seropositivity does not independently establish causation, and this is not a global estimate of etiologies or a treatment comparison.
Beyond Neuroretinitis: A Multi-Centre Study of Bartonella-Associated Uveitis
Classic neuroretinitis was present in half of eyes; other optic, retinal and inflammatory phenotypes were frequent. [6]
Limits and applicability: Referral and serological selection affect proportions. The study concerns ocular Bartonella presentations, not the percentage of all neuroretinitis caused by Bartonella.
Treatment Strategies for Neuroretinitis: Current Options and Emerging Therapies
Highlights uncertainty about antibiotics in uncomplicated Bartonella neuroretinitis and about systemic steroids, and separates recurrent idiopathic disease from infection. [7] [3]
Limits and applicability: Narrative review, not a new randomized trial. Updated 2025 review still identifies major evidence gaps, so regimens are not presented as proven comparative winners.
Questions researchers still need to answer
- Which cause- and severity-defined groups obtain a meaningful visual benefit from antimicrobial treatment beyond natural recovery?
- Can prospective studies identify when adjunctive immune treatment helps without increasing infectious risk?
- Which retinal and nerve measures best capture residual contrast, color or reading difficulty after acuity improves?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
CDC cat-scratch disease clinical overview
Current infection and testing information, including the distinction between usual cat-scratch disease and disseminated ocular disease; written for health professionals.
Ocular Immunology and Uveitis Foundation
Free ocular-inflammatory-disease self-help groups, including adult, parent and teen routes, plus virtual meetings. Broader than neuroretinitis; support is not diagnosis or personalized drug advice. Private group content was not inspected.
Connections listed by the organization.
NANOS specialist directory
Search neuro-ophthalmology professionals. Listing does not guarantee an appointment, insurance coverage or emergency access.
National Eye Institute low-vision resources
Information on vision rehabilitation, accessible devices and task adaptations; ask locally about referral and service availability.
Questions you may still have
Will I see a star in my vision?
The macular star refers to deposits seen during examination of the retina. It is not necessarily the shape of the visual disturbance a person experiences. [1] [2]
Does no macular star at the first visit rule it out?
No. Deposits can appear after initial disc swelling, so examination timing matters. The clinician also considers alternative causes rather than waiting without follow-up. [1] [2]
Is every case caused by a cat scratch?
No. Bartonella is important, but other infections and noninfectious causes exist. Some affected people do not recall a scratch, and regional exposure patterns differ. [3] [4]
Does improvement prove a medicine worked?
Not by itself. Some cases improve naturally, and treatment series often lack comparable untreated groups. Decisions still account for severity, immune status and the identified cause. [7]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- AAO EyeWiki — Neuroretinitis (2026; review).
Public full page read; update-pending editor status noted. Detailed drug suggestions not adopted as universal recommendations.
Checked 2026-10-24 · Public page checked - Ksiaa et al. — Update on Bartonella neuroretinitis (2019; review).
PubMed original abstract and indexed full-text passages checked; direct PMC reader challenged.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Shi, Danesh-Meyer and Bhatti — Neuroretinitis: a comprehensive review on aetiologies, clinical manifestations, and treatment options (2025; review).
Original indexed text checked; reader challenged. Published online November 2024, issue February 2025.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Choi et al. — Case series of neuroretinitis in Korea (2024; observational).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - CDC — Clinical Overview of Cat Scratch Disease (2026; institution).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Public page checked - Beyond Neuroretinitis: A Multi-Centre Study of Bartonella-Associated Uveitis (2026; observational).
Original indexed abstract read; direct PubMed reader returned no usable article body.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Fairbanks et al. — Treatment Strategies for Neuroretinitis: Current Options and Emerging Therapies (2019; review).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - OIUF — Support and virtual meeting calendar (n.d.; institution).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Public page checked - National Eye Institute — Low Vision (2025; institution).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Public page checked
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.